Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program

被引:308
|
作者
Beach, Thomas G. [1 ]
Adler, Charles H. [2 ]
Sue, Lucia I. [1 ]
Serrano, Geidy [1 ]
Shill, Holly A. [1 ]
Walker, Douglas G. [1 ]
Lue, LihFen [1 ]
Roher, Alex E. [1 ]
Dugger, Brittany N. [1 ]
Maarouf, Chera [1 ]
Birdsill, Alex C. [1 ]
Intorcia, Anthony [1 ]
Saxon-Labelle, Megan [1 ]
Pullen, Joel [1 ]
Scroggins, Alexander [1 ]
Filon, Jessica [1 ]
Scott, Sarah [1 ]
Hoffman, Brittany [1 ]
Garcia, Angelica [1 ]
Caviness, John N. [2 ]
Hentz, Joseph G. [2 ]
Driver-Dunckley, Erika [2 ]
Jacobson, Sandra A. [1 ]
Davis, Kathryn J. [1 ]
Belden, Christine M. [1 ]
Long, Kathy E. [1 ]
Malek-Ahmadi, Michael [1 ]
Powell, Jessica J. [1 ]
Gale, Lisa D. [1 ]
Nicholson, Lisa R. [1 ]
Caselli, Richard J. [2 ]
Woodruff, Bryan K. [2 ]
Rapscak, Steven Z. [3 ]
Ahern, Geoffrey L. [3 ]
Shi, Jiong [4 ]
Burke, Anna D. [5 ]
Reiman, Eric M. [5 ]
Sabbagh, Marwan N. [1 ]
机构
[1] Banner Sun Hlth Res Inst, Sun City, AZ USA
[2] Mayo Clin, Scottsdale, AZ USA
[3] Univ Arizona, Tucson, AZ USA
[4] Barrow Neurol Inst, Phoenix, AZ 85013 USA
[5] Banner Alzheimer Inst, Phoenix, AZ USA
关键词
aging; Alzheimer's disease; autopsy; biobank; biospecimen; brain bank; cancer; freeze-thaw; Parkinson's disease; pathology; post-mortem interval; RNA; AMYLOID-BETA-PEPTIDE; POSTMORTEM HUMAN-BRAIN; MESSENGER-RNA LEVELS; MILD COGNITIVE IMPAIRMENT; ALZHEIMERS ASSOCIATION GUIDELINES; PHOSPHORYLATED ALPHA-SYNUCLEIN; CEREBROSPINAL-FLUID BIOMARKERS; CYCLASE-ACTIVATING POLYPEPTIDE; AMPLITUDE CORTICAL MYOCLONUS; CLASSICAL COMPLEMENT PATHWAY;
D O I
10.1111/neup.12189
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The Brain and Body Donation Program (BBDP) at Banner Sun Health Research Institute () started in 1987 with brain-only donations and currently has banked more than 1600 brains. More than 430 whole-body donations have been received since this service was commenced in 2005. The collective academic output of the BBDP is now described as the Arizona Study of Aging and Neurodegenerative Disorders (AZSAND). Most BBDP subjects are enrolled as cognitively normal volunteers residing in the retirement communities of metropolitan Phoenix, Arizona. Specific recruitment efforts are also directed at subjects with Alzheimer's disease, Parkinson's disease and cancer. The median age at death is 82. Subjects receive standardized general medical, neurological, neuropsychological and movement disorders assessments during life and more than 90% receive full pathological examinations by medically licensed pathologists after death. The Program has been funded through a combination of internal, federal and state of Arizona grants as well as user fees and pharmaceutical industry collaborations. Subsets of the Program are utilized by the US National Institute on Aging Arizona Alzheimer's Disease Core Center and the US National Institute of Neurological Disorders and Stroke National Brain and Tissue Resource for Parkinson's Disease and Related Disorders. Substantial funding has also been received from the Michael J. Fox Foundation for Parkinson's Research. The Program has made rapid autopsy a priority, with a 3.0-hour median post-mortem interval for the entire collection. The median RNA Integrity Number (RIN) for frozen brain and body tissue is 8.9 and 7.4, respectively. More than 2500 tissue requests have been served and currently about 200 are served annually. These requests have been made by more than 400 investigators located in 32 US states and 15 countries. Tissue from the BBDP has contributed to more than 350 publications and more than 200 grant-funded projects.
引用
收藏
页码:354 / 389
页数:36
相关论文
共 50 条
  • [11] Autophagy in aging and in neurodegenerative disorders
    Rajawat, Yogendra S.
    Bossis, Ioannis
    HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2008, 7 (01): : 46 - 61
  • [12] BRAIN AGING - A RISK FACTOR OF NEURODEGENERATIVE DISORDERS AND A TARGET FOR THERAPEUTIC INTERVENTION
    MULLER, WE
    PEDIGO, NW
    LIFE SCIENCES, 1994, 55 (25-26) : 1975 - 1976
  • [13] Energy Metabolism Decline in the Aging Brain-Pathogenesis of Neurodegenerative Disorders
    Blaszczyk, Janusz Wieslaw
    METABOLITES, 2020, 10 (11) : 1 - 20
  • [14] The Brain Donation Program in South Korea
    Kim, Yeshin
    Suh, Yeon-Lim
    Kim, Seung Joo
    Bae, Moon Hwan
    Kim, Jae Bum
    Kim, Yuna
    Choi, Kyung-Chan
    Huh, Gi Yeong
    Kim, Eun-Joo
    Lee, Jung Seok
    Kang, Hyun Wook
    Shim, Sung-Mi
    Lim, Hyun Joung
    Koh, Young Ho
    Kim, Byeong-Chae
    Lee, Kyung-Hwa
    Lee, Min-Cheol
    Lee, Ho-Won
    Lim, Tae Sung
    Seeley, William W.
    Kim, Hee Jin
    Na, Duk L.
    Lee, Kyung Hoon
    Seo, Sang Won
    YONSEI MEDICAL JOURNAL, 2018, 59 (10) : 1197 - 1204
  • [15] Use of magnetoencephalography (MEG) to study functional brain networks in neurodegenerative disorders
    Stam, C. J.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2010, 289 (1-2) : 128 - 134
  • [16] Brain glucose and ketone utilization in brain aging and neurodegenerative diseases
    Kapogiannis, Dimitrios
    Avgerinos, Konstantinos I.
    METABOLIC AND BIOENERGETIC DRIVERS OF NEURODEGENERATIVE DISEASE: NEURODEGENERATIVE DISEASE RESEARCH AND COMMONALITIES WITH METABOLIC DISEASES, 2020, 154 : 79 - 110
  • [17] The role of iron in brain ageing and neurodegenerative disorders
    Ward, Roberta
    Zucca, Fabio A.
    Duyn, Jeff H.
    Crichton, Robert R.
    Zecca, Luigi
    LANCET NEUROLOGY, 2014, 13 (10) : 1045 - 1060
  • [18] Functional MRI of brain physiology in aging and neurodegenerative diseases
    Chen, J. Jean
    NEUROIMAGE, 2019, 187 : 209 - 225
  • [19] Neurodegenerative changes in human aging brain. An autopsy study
    Arsene, D.
    Ardeleanu, Carmen
    ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2010, 51 (01) : 55 - 60
  • [20] Preclinical Research of Dihydromyricetin for Brain Aging and Neurodegenerative Diseases
    Martinez-Coria, Hilda
    Mendoza-Rojas, Martha X.
    Arrieta-Cruz, Isabel
    Lopez-Valdes, Hector E.
    FRONTIERS IN PHARMACOLOGY, 2019, 10